Jack Phillips - 23 Jan 2024 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Executive Officer, Director
Signature: /s/ David Patience, attorney-in-fact
Issuer symbol: AXDX
Transactions as of: 23 Jan 2024
Transactions value $: $0
Form type: 4
Filing time: 25 Jan 2024, 16:11:34 UTC
Previous filing: 14 Dec 2023
Next filing: 02 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Award		+16.7K	+27.99%		76.2K	23 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Common Stock Warrants (right to buy)	Award		+16.7K			16.7K	23 Jan 2024	Common Stock	16.7K	$1.65	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are included within 16,666 units of the issuer (the "Units") purchased by the reporting person for $1.50 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock.